# Evaluation and Immunogenicity of Combined Liposome-Based Vaccine Candidates against Hepatitis E and B Viruses in Rhesus Monkeys

**Authors:** Tejaswini Deshmukh, Rachita Shah, Pradip Devhare, Kavita Lole, Vidya Arankalle

PMC · DOI: 10.3390/vaccines12010053 · 2024-01-05

## TL;DR

Researchers tested combined vaccines for hepatitis E and B in monkeys, finding that some formulations provided complete protection.

## Contribution

The study introduces a combined liposome-based vaccine for hepatitis E and B viruses and demonstrates its protective efficacy in rhesus monkeys.

## Key findings

- Monkeys vaccinated with Lipo-NE-DP and Lipo-NES-DP showed sterilizing immunity against hepatitis E and B.
- Anti-HEV and anti-HBV antibody levels were significantly higher in monkeys receiving DNA + protein formulations.
- None of the vaccinated monkeys showed viremia or liver enzyme elevation after challenge.

## Abstract

The administration of vaccines using a combination approach ensures better coverage and reduces the number of injections and cost. The present study assessed liposome-complexed DNA-corresponding proteins of hepatitis E and B viruses (HEV and HBV) as combined vaccine candidates in rhesus monkeys. The HEV and HBV components consisted of 450 bps, neutralizing the epitope/s (NE) region, and 685 bps small (S) envelope gene-corresponding proteins, respectively. Three groups (n = 2 monkeys/group) were intramuscularly immunized with a total of three doses of NE Protein (Lipo-NE-P), NE DNA + Protein (Lipo-NE-DP), and each of NE and S DNA + Protein (Lipo-NES-DP), respectively, given one month apart. All immunized monkeys were challenged with 10,000 fifty percent monkey infectious dose of homologous HEV strain. Post-immunization anti-HEV antibody levels in monkeys were 59.4 and 148.4 IU/mL (Lipo-NE-P), 177.0 and 240.8 IU/mL (Lipo-NE-DP), and 240.7 and 164.9 IU/mL (Lipo-NES-DP). Anti-HBV antibody levels in Lipo-NES-DP immunized monkeys were 58,786 and 6213 mIU/mL. None of the challenged monkeys showed viremia and elevation in serum alanine amino transferase levels. Monkeys immunized with Lipo-NE-DP and Lipo-NES-DP exhibited a sterilizing immunity, indicating complete protection, whereas monkeys immunized with Lipo-NE-P showed limited viral replication. In conclusion, the liposome-complexed DNA-corresponding proteins of HEV and HBV induced protective humoral immune responses to both components in monkeys and are worth exploring further.

## Linked entities

- **Diseases:** hepatitis B (MONDO:0005344)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, NES (nestin) [NCBI Gene 10763] {aka Nbla00170}, ORF2 [NCBI Gene 1494410], VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}
- **Diseases:** Hepatitis E (MESH:D016751), PC (MESH:D000094025), non (MESH:C580335), hepatitis (MESH:D056486), ACLF (MESH:D065290), COVID-19 (MESH:D000086382), ND (MESH:C537849), ALF (MESH:D017114), HEV Infection (MESH:D007239), -limiting acute viral hepatitis (MESH:D006525), EI (MESH:D009374), injury to people or property (MESH:C000719191), acute (MESH:D000208), Hepatitis E and B Viruses (MESH:D006509), viremia (MESH:D014766)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Macaca mulatta (rhesus macaque, species) [taxon 9544], Cercopithecidae (monkey, family) [taxon 9527], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10820018/full.md

---
Source: https://tomesphere.com/paper/PMC10820018